Search Results - "Kupper, H"

Chaotic dispersal of tidal debris by Price-Whelan, Adrian M, Johnston, Kathryn V, Valluri, Monica, Pearson, Sarah, Kuepper, Andreas H W, Hogg, David W

“…Several long, dynamically cold stellar streams have been observed around the Milky Way Galaxy, presumably formed from the tidal disruption of globular…”
Get full text

EXPLODING SATELLITES-THE TIDAL DEBRIS OF THE ULTRA-FAINT DWARF GALAXY HERCULES by Küpper, Andreas H. W., Johnston, Kathryn V., Mieske, Steffen, Collins, Michelle L. M., Tollerud, Erik J.

“…ABSTRACT The ultra-faint satellite galaxy Hercules has a strongly elongated and irregular morphology with detections of tidal features up to 1.3 deg (3 kpc)…”
Get full text

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study by Rudwaleit, M, Rødevand, E, Holck, P, Vanhoof, J, Kron, M, Kary, S, Kupper, H

“…To evaluate the effect of adalimumab on the frequency of anterior uveitis (AU) flares in patients with active ankylosing spondylitis (AS). We determined the…”
Get more information

On the structure of tidal tails by Küpper, Andreas H. W., Macleod, Andrew, Heggie, Douglas C.

“…We examine the longitudinal distribution of the stars escaping from a cluster along tidal tails. Using both theory and simulations, we show that, even in the…”
Get full text

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis by Schiff, M H, Burmester, G R, Kent, J D, Pangan, A L, Kupper, H, Fitzpatrick, S B, Donovan, C

“…Objective: To assess the safety of adalimumab in global clinical trials and postmarketing surveillance among patients with rheumatoid arthritis (RA). Methods:…”
Get full text

Health hazards due to the inhalation of amorphous silica by MERGET, R, BAUER, T, KÜPPER, H. U, PHILIPPOU, S, BAUER, H. D, BREITSTADT, R, BRUENING, T

“…Occupational exposure to crystalline silica dust is associated with an increased risk for pulmonary diseases such as silicosis, tuberculosis, chronic…”
Get full text

Quantifying tidal stream disruption in a simulated Milky Way by Sandford, Emily, Küpper, Andreas H. W., Johnston, Kathryn V., Diemand, Jürg

“…Abstract Simulations of tidal streams show that close encounters with dark matter subhaloes induce density gaps and distortions in on-sky path along the…”
Get full text

Long‐Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non–Radiographically Evident Axial Spondyloarthritis Who Experience a Flare by Haibel, H., Heldmann, F., Braun, J., Listing, J., Kupper, H., Sieper, J.

Get full text

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial by van der Heijde, D, Schiff, M H, Sieper, J, Kivitz, A J, Wong, R L, Kupper, H, Dijkmans, B A C, Mease, P J, Davis, Jr, J C

“…To determine the long-term effect of adalimumab on patients with ankylosing spondylitis (AS) who participated in the Adalimumab Trial Evaluating Long-Term…”
Get more information

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed by van de Putte, L B A, Atkins, C, Malaise, M, Sany, J, Russell, A S, van Riel, P L C M, Settas, L, Bijlsma, J W, Todesco, S, Dougados, M, Nash, P, Emery, P, Walter, N, Kaul, M, Fischkoff, S, Kupper, H

“…Objective: To evaluate the efficacy and safety of monotherapy with adalimumab in patients with RA for whom previous DMARD treatment has failed. Methods: In a…”
Get full text

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions by Van den Bosch, F, Manger, B, Goupille, P, McHugh, N, Rødevand, E, Holck, P, van Vollenhoven, R F, Leirisalo-Repo, M, Fitzgerald, O, Kron, M, Frank, M, Kary, S, Kupper, H

“…To evaluate the effectiveness of adalimumab in patients with psoriatic arthritis (PsA) and identify predictors of good clinical response for joint and skin…”
Get more information

Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice by Bombardieri, S., Ruiz, A. A., Fardellone, P., Geusens, P., McKenna, F., Unnebrink, K., Oezer, U., Kary, S., Kupper, H., Burmester, G. R.

“…Objective. To evaluate the effectiveness and safety of adalimumab in patients with rheumatoid arthritis (RA) who previously discontinued tumour necrosis factor…”
Get full text

Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells by Krüger-Genge, A, Jung, F, Hufert, F, Jung, E-M, Küpper, J-H, Storsberg, J

“…Thrombotic events result from different pathologies and are the underlying causes of severe diseases like stroke or myocardial infarction. Recent basic…”
Get more information

A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study by Thaçi, D., Ortonne, J.-P., Chimenti, S., Ghislain, P.-D., Arenberger, P., Kragballe, K., Saurat, J.-H., Khemis, A., Sprøgel, P., Esslinger, H.-U., Unnebrink, K., Kupper, H.

“…Summary Background  Data are lacking on the use of topical therapies in combination with tumour necrosis factor blockers for the treatment of psoriasis…”
Get full text

Voices of society: the emergence of civil-society practices aiming to engage in the management of the COVID-19 pandemic in the Netherlands by Kemper, Sophie, van den Broek, Renate, van Hameren, Sarah, Kupper, J Frank H, Bongers, Marloes E J, de Weger, Esther, de Vries, Marion, Timen, Aura

“…During the COVID-19 pandemic, public groups mobilised themselves in civil-society engagement practices (CSEPs) aiming to improve or suggest alternative…”
Get full text

Formation of massive black holes in galactic nuclei: runaway tidal encounters by Stone, Nicholas C., Küpper, Andreas H. W., Ostriker, Jeremiah P.

“…Abstract Nuclear star clusters (NSCs) and supermassive black holes (SMBHs) both inhabit galactic nuclei, coexisting in a range of bulge masses, but excluding…”
Get full text

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis by Miceli-Richard, C, Comets, E, Verstuyft, C, Tamouza, R, Loiseau, P, Ravaud, P, Kupper, H, Becquemont, L, Charron, D, Mariette, X

“…To determine whether tumour necrosis factor (TNF) gene polymorphisms and/or the shared epitope are genetic predictors of the response to adalimumab (ADA) in…”
Get more information

Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE by Ortonne, J.-P., Chimenti, S., Reich, K., Gniadecki, R., Sprøgel, P., Unnebrink, K., Kupper, H., Goldblum, O., Thaçi, D.

“…Background  Few large clinical studies have evaluated whether switching tumour necrosis factor antagonists (anti‐TNFs) is likely to improve psoriasis in…”
Get full text

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis by van der Heijde, D, Pangan, A L, Schiff, M H, Braun, J, Borofsky, M, Torre, J, Davis, Jr, J C, Wong, R L, Kupper, H, Collantes, E

“…To evaluate the long-term safety and efficacy of adalimumab in patients with ankylosing spondylitis (AS) and total spinal ankylosis (TSA). Patients (n = 315)…”
Get more information

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study by van de Putte, L B A, Rau, R, Breedveld, F C, Kalden, J R, Malaise, M G, van Riel, P L C M, Schattenkirchner, M, Emery, P, Burmester, G R, Zeidler, H, Moutsopoulos, H M, Beck, K, Kupper, H

“…Objectives: To evaluate efficacy, dose response, safety, and tolerability of adalimumab (D2E7) in disease modifying antirheumatic drug (DMARD) refractory…”
Get full text